CD4 and neoplasm: Our results found that MDSCs (CD11b+Gr1+) and Tregs (CD4+CD25+Foxp3+) were elevated significantly on days 21 and 28 after tumor implantation (Supplementary Fig. 1a, b), indicating that both Tregs and MDSCs might affect host tumor immune response.